Webinars
Keep it real. Available to watch on demand.
We are a trusted partner for real-world evidence and patient-centred outcomes research, leveraging the Vitaccess Real™ platform to generate actionable insights. Our “Keeping it Real” webinar series explores RWE, PROs, and outcomes research, featuring special guests from industry. All webinars are available on demand, so you can access expert insights anytime.
Why is the caregiver perspective more important than ever in real-world studies?
On March 2, 2022, we held a webinar on the importance of including the caregiver perspective in real-world studies. Here, we delve into some of the ideas that were discussed.
What is the point of real-world evidence?
On Friday 15th September, we hosted the 19th webinar in our “Keeping it real” series: What is the point of real-world evidence? Real-world evidence...
Longitudinal real-world evidence in rare diseases
Mark Larkin and Catherine Bottomley discuss how to excel at generating longitudinal real-world evidence, with a focus on rare diseases.
Ethics in patient-centered real-world studies
On June 14th, we hosted the 17th webinar in our “Keeping it real” series: How to approach ethics in patient-centered real-world studies Sam...
Data storytelling in patient-centric research
Harshitha Ravindra and Laura Day discuss how real-world patient-centric data can be used to effectively map the patient journey.
Maximizing the potential of your digital patient-centric study
On March 29, we hosted the 15th webinar in our “Keeping it real” series: “How to design a study app for a real-world study”. Jon Spinage, CTO, and...
How to successfully implement a digital real-world study
How to successfully implement a digital real-world study. Approaches in rare disease and oncology On 21st February, we hosted the 14th webinar in...
Designing a digital patient-reported real-world study
On 25th January, we hosted the 13th webinar in the “Keeping it real” series. How to design a digital real-world study? Real-World Evidence...
KIR#12 – Patient engagement and retention in real-world studies
Sam Llewellyn, Senior Consultant, and Dr Mark Larkin, CEO and Founder of Vitaccess, presented examples of real-world studies where patient retention...
KIR #11 – Capturing and quantifying micro-moments in RWE research
On September 28, we hosted the latest webinar in our “Keeping it real” series. Sally Vincent, Senior Consultant in Patient-Centered Outcomes, and Dr Mark Larkin, Founder and CEO of Vitaccess, discussed capturing, characterizing, and quantifying micro-moments in patients’ daily lives using digital real-world evidence technologies.
KIR #10 – Real-world data for medical device access
On August 24, we hosted the latest webinar in our “Keeping it real” series.
Steven Haken, Founder and CEO of Odelle Technology, Claire Edwards, Consultant at Odelle Technology, and Dr Mark Larkin, Founder and CEO of Vitaccess, discussed using prospectively generated patient-centric real-world data to support access for medical devices.
During the webinar, they explored how patient-reported real-world data can help demonstrate the value proposition of your device or product.
Keeping it real #9 – Patient engagement in the publication of real-world evidence
On July 20, we hosted the latest webinar in our “Keeping it real” series – the first in partnership with Envision Pharma Group since we joined forces earlier this year.
Dr Dawn Lobban, Global Lead, Patient Partnerships at Envision the Patient (part of the Envision Pharma Group), and Dr Catherine Bottomley, Chief Scientific Officer at Vitaccess, discussed patient engagement in the publication of real-world evidence.
Watch on-demand!
Keeping it real #8 – How to avoid obstacles to digital RWE analytics
On the 21st June 2022, Vitaccess hosted its “Keeping it real” webinar on how to avoid obstacles to digital RWE analytics. Dr Casey Quinn, Chief Research Officer, and Amber Kudlac, Associate Director, discussed their experiences of these obstacles and barriers, and, crucially, how to avoid them.
Keeping it real #7 – Diagnosis validation in patient-centered research
Dr Catherine Bottomley, Chief Scientific Officer, and Sam Llewellyn, Senior Consultant, discussed diagnosis validation in patient-centered research – specifically, alternatives to clinician-led eligibility confirmation for decentralized studies.A core part in recruiting for patient- and caregiver-reported studies is verifying eligibility of the prospective participant, referred to as diagnosis “validation”.
Keeping it real #6 – Generating RWE to support NICE severity modifier modelling
Dr Mark Larkin and Dr Casey Quinn discussed the generation of real-world evidence to support NICE severity modifier modelling. They covered the recent update by NICE to its methods and processes for health technology assessment, which includes a number of significant changes to how innovative medicines will be evaluated for pricing and reimbursement in the UK.
Keeping it real #5 – Importance of caregiver perspective in real-world evidence
Missed our webinar about the importance of caregiver perspective in real-world studies? Watch it here! On March 2, we hosted the 5th webinar...
Keeping it real #4 – Safety reporting in pre- to post-approval RWE studies
A webinar on adding safety reporting to create continuous pre- to post-approval longitudinal digital RWE studies. Special guest Esther Daemen.
Keeping it real #3 – Co-creating rare disease registries
On Monday 15th November, Vitaccess hosted the 3rd webinar in the “Keeping it real” series.
Dr Mark Larkin, CEO and Founder of Vitaccess; Dr Catherine Bottomley, Director of Patient-Centered Outcomes; and Dr Casey Quinn, Chief Research Officer, presented a free webinar on the topic of “Co-creating rare disease registries”.
Keeping it real #2 – Digital endpoints and HEOR – moving towards a richer understanding of disease impact and therapeutic benefit.
Adverse events (AEs), particularly with drug therapies, remain a challenge in modern healthcare. The increasing complexity of cancer therapeutics, an ageing population, and rising multimorbidity all continue to contribute to and complicate safety issues for patients. However, while our understanding of AEs should be evolving, and our AE storytelling for patients should be more engaging, reporting of AEs really has not changed. Indeed, AE narratives remain directed at clinicians and regulators, rather than to patients. We believe there is value in being able to tell patients an AE narrative.
Keeping it real #1 – real-world evidence in rare disease
Adverse events (AEs), particularly with drug therapies, remain a challenge in modern healthcare. The increasing complexity of cancer therapeutics, an ageing population, and rising multimorbidity all continue to contribute to and complicate safety issues for patients. However, while our understanding of AEs should be evolving, and our AE storytelling for patients should be more engaging, reporting of AEs really has not changed. Indeed, AE narratives remain directed at clinicians and regulators, rather than to patients. We believe there is value in being able to tell patients an AE narrative.
